Supply Chain Intelligence about:
France
| 日期 | 供应商 | 客户 | 详细信息 | 43 more fields |
|---|---|---|---|---|
| 2025-11-06 | Lilly France |
Jabil Healthcare
|
XXXXX XXXXXXX XXXXX XX XXXXXXX
|
货运提单 |
| 2025-11-06 | Lilly France |
Jabil Healthcare
|
XX XXXXX XXXXXXX XXXXX XX XXXXXXX X XX XXXXX XXXXXXX XXXXX XX XXXXXXX X XX XXXXX XXXXXXX XXXXX XX XXXXXXX X XX XXXXX XXXXXXX XXXXX XX XXXXXXX X XX XXXXX XXXXXXX XXXXX XX XXXXXXX
|
货运提单 |
| 2025-11-06 | Lilly France |
Jabil Healthcare
|
XX XXXXX XXXXXXX XXXXX XX XXXXXXXXXXXXXXXX XXX XXXXXXX XX XX XXXX XXXXXXX XXXXXXX X XX XXXXX XX X XX XXXXX XXXXXXX XXXXX XX XXXXXXXXXXXXXXXX XXX XXXXXXX XX XX XXXX XXXXXXX XXXXXXX X XX XXXXX XX X XX XXXXX XXXXXXX XXXXX XX XXXXXXXXXXXXXXXX XXX XXXXXXX XX XX XXXX XXXXXXX XXXXXXX X XX XXXXX XX X XX XXXXX XXXXXXX XXXXX XX XXXXXXXXXXXXXXXX XXX XXXXXXX XX XX XXXX XXXXXXX XXXXXXX X XX XXXXX XX X XX XXXXX
|
货运提单 |
The administration of President Donald Trump may be willing to drop proposals related to standardized biologic drug patent lengths in order to secure passage of the U.S.-Mexico-Canada Agreement, USMCA, through the U.S. House of Representatives. Setting patent protections to 10 years across the... Read more →
The global prevalence of diabetes is growing, but can be a tough sector for pharmaceutical companies to make money in as recent results from Novo Nordisk and Eli Lilly demonstrate. Panjiva data shows that U.S. imports of insulin and related equipment fell 15% in the third quarter in dollar ter... Read more →
中文